Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
August 12, 2020 at 03:04 pm EDT
BioGend Therapeutics Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 485,000 compared to TWD 741,000 a year ago. Operating loss was TWD 64.185 million compared to TWD 76.004 million a year ago. Net loss was TWD 70.113 million compared to TWD 74.234 million a year ago. Basic loss per share was TWD 0.85 compared to TWD 0.92 a year ago.